APO Research
Talk to an analyst

APO RESEARCH · REPORT

Venous Leg Ulcers Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Venous Leg Ulcers Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchVenous Leg Ulcers Treatment Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Venous Leg Ulcers Treatment Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Venous Leg Ulcers Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Venous Leg Ulcers Treatment Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Venous Leg Ulcers Treatment Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Venous Leg Ulcers Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Venous Leg Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Venous Leg Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Venous Leg Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Venous Leg Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Venous Leg Ulcers Treatment include Stratatech Corp, RMB-Research GmbH, RegeneRx Biopharmaceuticals Inc, Promore Pharma, NovaLead Pharma Pvt Ltd, MediWound Ltd, Leap Therapeutics Inc, Hypo-Stream Ltd and GangaGen Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Venous Leg Ulcers Treatment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Venous Leg Ulcers Treatment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Venous Leg Ulcers Treatment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Venous Leg Ulcers Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Venous Leg Ulcers Treatment Segment by Company

Stratatech Corp

RMB-Research GmbH

RegeneRx Biopharmaceuticals Inc

Promore Pharma

NovaLead Pharma Pvt Ltd

MediWound Ltd

Leap Therapeutics Inc

Hypo-Stream Ltd

GangaGen Inc

FirstString Research Inc

Factor Therapeutics Ltd

Daval International Ltd

CytoTools AG

CardioVascular BioTherapeutics Inc

Venous Leg Ulcers Treatment Segment by Type

HP-802247

Granexin

CVBT-141B

CureXcell

Others

Venous Leg Ulcers Treatment Segment by Application

Hospital

Clinic

Home Use

Venous Leg Ulcers Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Venous Leg Ulcers Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Venous Leg Ulcers Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Venous Leg Ulcers Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Venous Leg Ulcers Treatment market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Venous Leg Ulcers Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Venous Leg Ulcers Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Venous Leg Ulcers Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Venous Leg Ulcers Treatment Industry Trends Table 2. Venous Leg Ulcers Treatment Industry Drivers Table 3. Venous Leg Ulcers Treatment Industry Opportunities and Challenges Table 4. Venous Leg Ulcers Treatment Industry Restraints Table 5. Global Venous Leg Ulcers Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Venous Leg Ulcers Treatment Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Venous Leg Ulcers Treatment Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Venous Leg Ulcers Treatment Sales Market Share by Manufacturers Table 9. Global Venous Leg Ulcers Treatment Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Venous Leg Ulcers Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Venous Leg Ulcers Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Venous Leg Ulcers Treatment Manufacturers, Product Type & Application Table 13. Global Venous Leg Ulcers Treatment Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Venous Leg Ulcers Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of HP-802247 Table 17. Major Manufacturers of Granexin Table 18. Major Manufacturers of CVBT-141B Table 19. Major Manufacturers of CureXcell Table 20. Major Manufacturers of Others Table 21. Global Venous Leg Ulcers Treatment Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Venous Leg Ulcers Treatment Sales by Type (2021-2026) & (k units) Table 23. Global Venous Leg Ulcers Treatment Sales by Type (2027-2032) & (k units) Table 24. Global Venous Leg Ulcers Treatment Sales Market Share by Type (2021-2026) Table 25. Global Venous Leg Ulcers Treatment Sales Market Share by Type (2027-2032) Table 26. Global Venous Leg Ulcers Treatment Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Venous Leg Ulcers Treatment Revenue by Type (2021-2026) & (k units) Table 28. Global Venous Leg Ulcers Treatment Revenue by Type (2027-2032) & (k units) Table 29. Global Venous Leg Ulcers Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Venous Leg Ulcers Treatment Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Major Manufacturers of Home Use Table 34. Global Venous Leg Ulcers Treatment Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Venous Leg Ulcers Treatment Sales by Application (2021-2026) & (k units) Table 36. Global Venous Leg Ulcers Treatment Sales by Application (2027-2032) & (k units) Table 37. Global Venous Leg Ulcers Treatment Sales Market Share by Application (2021-2026) Table 38. Global Venous Leg Ulcers Treatment Sales Market Share by Application (2027-2032) Table 39. Global Venous Leg Ulcers Treatment Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Venous Leg Ulcers Treatment Revenue by Application (2021-2026) & (k units) Table 41. Global Venous Leg Ulcers Treatment Revenue by Application (2027-2032) & (k units) Table 42. Global Venous Leg Ulcers Treatment Revenue Market Share by Application (2021-2026) Table 43. Global Venous Leg Ulcers Treatment Revenue Market Share by Application (2027-2032) Table 44. Global Venous Leg Ulcers Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Venous Leg Ulcers Treatment Sales by Region (2021-2026) & (k units) Table 46. Global Venous Leg Ulcers Treatment Sales Market Share by Region (2021-2026) Table 47. Global Venous Leg Ulcers Treatment Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Venous Leg Ulcers Treatment Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Venous Leg Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Venous Leg Ulcers Treatment Sales by Country (2021-2026) & (k units) Table 51. North America Venous Leg Ulcers Treatment Sales by Country (2027-2032) & (k units) Table 52. Europe Venous Leg Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Venous Leg Ulcers Treatment Sales by Country (2021-2026) & (k units) Table 54. Europe Venous Leg Ulcers Treatment Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Venous Leg Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Venous Leg Ulcers Treatment Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Venous Leg Ulcers Treatment Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Venous Leg Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Venous Leg Ulcers Treatment Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Venous Leg Ulcers Treatment Sales by Country (2027-2032) & (k units) Table 61. Global Venous Leg Ulcers Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Venous Leg Ulcers Treatment Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Venous Leg Ulcers Treatment Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Venous Leg Ulcers Treatment Revenue Market Share by Region (2021-2026) Table 65. Global Venous Leg Ulcers Treatment Revenue Market Share by Region (2027-2032) Table 66. Stratatech Corp Company Information Table 67. Stratatech Corp Business Overview Table 68. Stratatech Corp Venous Leg Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Stratatech Corp Venous Leg Ulcers Treatment Product Portfolio Table 70. Stratatech Corp Recent Development Table 71. RMB-Research GmbH Company Information Table 72. RMB-Research GmbH Business Overview Table 73. RMB-Research GmbH Venous Leg Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. RMB-Research GmbH Venous Leg Ulcers Treatment Product Portfolio Table 75. RMB-Research GmbH Recent Development Table 76. RegeneRx Biopharmaceuticals Inc Company Information Table 77. RegeneRx Biopharmaceuticals Inc Business Overview Table 78. RegeneRx Biopharmaceuticals Inc Venous Leg Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. RegeneRx Biopharmaceuticals Inc Venous Leg Ulcers Treatment Product Portfolio Table 80. RegeneRx Biopharmaceuticals Inc Recent Development Table 81. Promore Pharma Company Information Table 82. Promore Pharma Business Overview Table 83. Promore Pharma Venous Leg Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Promore Pharma Venous Leg Ulcers Treatment Product Portfolio Table 85. Promore Pharma Recent Development Table 86. NovaLead Pharma Pvt Ltd Company Information Table 87. NovaLead Pharma Pvt Ltd Business Overview Table 88. NovaLead Pharma Pvt Ltd Venous Leg Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. NovaLead Pharma Pvt Ltd Venous Leg Ulcers Treatment Product Portfolio Table 90. NovaLead Pharma Pvt Ltd Recent Development Table 91. MediWound Ltd Company Information Table 92. MediWound Ltd Business Overview Table 93. MediWound Ltd Venous Leg Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. MediWound Ltd Venous Leg Ulcers Treatment Product Portfolio Table 95. MediWound Ltd Recent Development Table 96. Leap Therapeutics Inc Company Information Table 97. Leap Therapeutics Inc Business Overview Table 98. Leap Therapeutics Inc Venous Leg Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Leap Therapeutics Inc Venous Leg Ulcers Treatment Product Portfolio Table 100. Leap Therapeutics Inc Recent Development Table 101. Hypo-Stream Ltd Company Information Table 102. Hypo-Stream Ltd Business Overview Table 103. Hypo-Stream Ltd Venous Leg Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Hypo-Stream Ltd Venous Leg Ulcers Treatment Product Portfolio Table 105. Hypo-Stream Ltd Recent Development Table 106. GangaGen Inc Company Information Table 107. GangaGen Inc Business Overview Table 108. GangaGen Inc Venous Leg Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. GangaGen Inc Venous Leg Ulcers Treatment Product Portfolio Table 110. GangaGen Inc Recent Development Table 111. FirstString Research Inc Company Information Table 112. FirstString Research Inc Business Overview Table 113. FirstString Research Inc Venous Leg Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. FirstString Research Inc Venous Leg Ulcers Treatment Product Portfolio Table 115. FirstString Research Inc Recent Development Table 116. Factor Therapeutics Ltd Company Information Table 117. Factor Therapeutics Ltd Business Overview Table 118. Factor Therapeutics Ltd Venous Leg Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Factor Therapeutics Ltd Venous Leg Ulcers Treatment Product Portfolio Table 120. Factor Therapeutics Ltd Recent Development Table 121. Daval International Ltd Company Information Table 122. Daval International Ltd Business Overview Table 123. Daval International Ltd Venous Leg Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Daval International Ltd Venous Leg Ulcers Treatment Product Portfolio Table 125. Daval International Ltd Recent Development Table 126. CytoTools AG Company Information Table 127. CytoTools AG Business Overview Table 128. CytoTools AG Venous Leg Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. CytoTools AG Venous Leg Ulcers Treatment Product Portfolio Table 130. CytoTools AG Recent Development Table 131. CardioVascular BioTherapeutics Inc Company Information Table 132. CardioVascular BioTherapeutics Inc Business Overview Table 133. CardioVascular BioTherapeutics Inc Venous Leg Ulcers Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. CardioVascular BioTherapeutics Inc Venous Leg Ulcers Treatment Product Portfolio Table 135. CardioVascular BioTherapeutics Inc Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. Venous Leg Ulcers Treatment Distributors List Table 139. Venous Leg Ulcers Treatment Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Venous Leg Ulcers Treatment Product Image Figure 2. Global Venous Leg Ulcers Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Venous Leg Ulcers Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Venous Leg Ulcers Treatment Sales (2021-2032) & (k units) Figure 5. Global Venous Leg Ulcers Treatment Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Venous Leg Ulcers Treatment Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. HP-802247 Image Figure 9. Granexin Image Figure 10. CVBT-141B Image Figure 11. CureXcell Image Figure 12. Others Image Figure 13. Global Venous Leg Ulcers Treatment Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Venous Leg Ulcers Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Venous Leg Ulcers Treatment Sales Market Share by Type (2021-2032) Figure 16. Global Venous Leg Ulcers Treatment Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Venous Leg Ulcers Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Venous Leg Ulcers Treatment Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Home Use Image Figure 22. Global Venous Leg Ulcers Treatment Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Venous Leg Ulcers Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Venous Leg Ulcers Treatment Sales Market Share by Application (2021-2032) Figure 25. Global Venous Leg Ulcers Treatment Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Venous Leg Ulcers Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Venous Leg Ulcers Treatment Revenue Market Share by Application (2021-2032) Figure 28. North America Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Venous Leg Ulcers Treatment Sales Market Share by Country (2021-2032) Figure 30. U.S. Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Venous Leg Ulcers Treatment Sales Market Share by Country (2021-2032) Figure 35. Germany Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Venous Leg Ulcers Treatment Sales Market Share by Country (2021-2032) Figure 42. China Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Venous Leg Ulcers Treatment Sales Market Share by Country (2021-2032) Figure 50. Brazil Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Venous Leg Ulcers Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Venous Leg Ulcers Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Venous Leg Ulcers Treatment Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Venous Leg Ulcers Treatment Revenue (2021-2032) & (US$ Million) Figure 61. North America Venous Leg Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Venous Leg Ulcers Treatment Revenue (2021-2032) & (US$ Million) Figure 63. Europe Venous Leg Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Venous Leg Ulcers Treatment Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Venous Leg Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Venous Leg Ulcers Treatment Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Venous Leg Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Venous Leg Ulcers Treatment Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Venous Leg Ulcers Treatment Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • HP-802247
  • Granexin
  • CVBT-141B
  • CureXcell
  • Others
Applications
  • Hospital
  • Clinic
  • Home Use
Companies covered
  • Stratatech Corp
  • RMB-Research GmbH
  • RegeneRx Biopharmaceuticals Inc
  • Promore Pharma
  • NovaLead Pharma Pvt Ltd
  • MediWound Ltd
  • Leap Therapeutics Inc
  • Hypo-Stream Ltd
  • GangaGen Inc
  • FirstString Research Inc
  • Factor Therapeutics Ltd
  • Daval International Ltd
  • CytoTools AG
  • CardioVascular BioTherapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Venous Leg Ulcers Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Venous Leg Ulcers Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Venous Leg Ulcers Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Venous Leg Ulcers Treatment Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Venous Leg Ulcers Treatment Market Dynamics
  1. 2.1 Venous Leg Ulcers Treatment Industry Trends
  2. 2.2 Venous Leg Ulcers Treatment Industry Drivers
  3. 2.3 Venous Leg Ulcers Treatment Industry Opportunities and Challenges
  4. 2.4 Venous Leg Ulcers Treatment Industry Restraints
3 Venous Leg Ulcers Treatment Market by Manufacturers
  1. 3.1 Global Venous Leg Ulcers Treatment Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Venous Leg Ulcers Treatment Sales by Manufacturers (2021-2026)
  3. 3.3 Global Venous Leg Ulcers Treatment Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Venous Leg Ulcers Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Venous Leg Ulcers Treatment Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Venous Leg Ulcers Treatment Manufacturers, Product Type & Application
  7. 3.7 Global Venous Leg Ulcers Treatment Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Venous Leg Ulcers Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Venous Leg Ulcers Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Venous Leg Ulcers Treatment Tier 1, Tier 2, and Tier 3
4 Venous Leg Ulcers Treatment Market by Type
  1. 4.1 Venous Leg Ulcers Treatment Type Introduction
  2. 4.1.1 HP-802247
  3. 4.1.2 Granexin
  4. 4.1.3 CVBT-141B
  5. 4.1.4 CureXcell
  6. 4.1.5 Others
  7. 4.2 Global Venous Leg Ulcers Treatment Sales by Type
  8. 4.2.1 Global Venous Leg Ulcers Treatment Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Venous Leg Ulcers Treatment Sales by Type (2021-2032)
  10. 4.2.3 Global Venous Leg Ulcers Treatment Sales Market Share by Type (2021-2032)
  11. 4.3 Global Venous Leg Ulcers Treatment Revenue by Type
  12. 4.3.1 Global Venous Leg Ulcers Treatment Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Venous Leg Ulcers Treatment Revenue by Type (2021-2032)
  14. 4.3.3 Global Venous Leg Ulcers Treatment Revenue Market Share by Type (2021-2032)
5 Venous Leg Ulcers Treatment Market by Application
  1. 5.1 Venous Leg Ulcers Treatment Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Home Use
  5. 5.2 Global Venous Leg Ulcers Treatment Sales by Application
  6. 5.2.1 Global Venous Leg Ulcers Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Venous Leg Ulcers Treatment Sales by Application (2021-2032)
  8. 5.2.3 Global Venous Leg Ulcers Treatment Sales Market Share by Application (2021-2032)
  9. 5.3 Global Venous Leg Ulcers Treatment Revenue by Application
  10. 5.3.1 Global Venous Leg Ulcers Treatment Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Venous Leg Ulcers Treatment Revenue by Application (2021-2032)
  12. 5.3.3 Global Venous Leg Ulcers Treatment Revenue Market Share by Application (2021-2032)
6 Global Venous Leg Ulcers Treatment Sales by Region
  1. 6.1 Global Venous Leg Ulcers Treatment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Venous Leg Ulcers Treatment Sales by Region (2021-2032)
  3. 6.2.1 Global Venous Leg Ulcers Treatment Sales by Region (2021-2026)
  4. 6.2.2 Global Venous Leg Ulcers Treatment Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Venous Leg Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Venous Leg Ulcers Treatment Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Venous Leg Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Venous Leg Ulcers Treatment Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Venous Leg Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Venous Leg Ulcers Treatment Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Venous Leg Ulcers Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Venous Leg Ulcers Treatment Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Venous Leg Ulcers Treatment Revenue by Region
  1. 7.1 Global Venous Leg Ulcers Treatment Revenue by Region
  2. 7.1.1 Global Venous Leg Ulcers Treatment Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Venous Leg Ulcers Treatment Revenue by Region (2021-2026)
  4. 7.1.3 Global Venous Leg Ulcers Treatment Revenue by Region (2027-2032)
  5. 7.1.4 Global Venous Leg Ulcers Treatment Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Venous Leg Ulcers Treatment Revenue (2021-2032)
  8. 7.2.2 North America Venous Leg Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Venous Leg Ulcers Treatment Revenue (2021-2032)
  11. 7.3.2 Europe Venous Leg Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Venous Leg Ulcers Treatment Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Venous Leg Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Venous Leg Ulcers Treatment Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Venous Leg Ulcers Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Stratatech Corp
  2. 8.1.1 Stratatech Corp Company Information
  3. 8.1.2 Stratatech Corp Business Overview
  4. 8.1.3 Stratatech Corp Venous Leg Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Stratatech Corp Venous Leg Ulcers Treatment Product Portfolio
  6. 8.1.5 Stratatech Corp Recent Developments
  7. 8.2 RMB-Research GmbH
  8. 8.2.1 RMB-Research GmbH Company Information
  9. 8.2.2 RMB-Research GmbH Business Overview
  10. 8.2.3 RMB-Research GmbH Venous Leg Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 RMB-Research GmbH Venous Leg Ulcers Treatment Product Portfolio
  12. 8.2.5 RMB-Research GmbH Recent Developments
  13. 8.3 RegeneRx Biopharmaceuticals Inc
  14. 8.3.1 RegeneRx Biopharmaceuticals Inc Company Information
  15. 8.3.2 RegeneRx Biopharmaceuticals Inc Business Overview
  16. 8.3.3 RegeneRx Biopharmaceuticals Inc Venous Leg Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 RegeneRx Biopharmaceuticals Inc Venous Leg Ulcers Treatment Product Portfolio
  18. 8.3.5 RegeneRx Biopharmaceuticals Inc Recent Developments
  19. 8.4 Promore Pharma
  20. 8.4.1 Promore Pharma Company Information
  21. 8.4.2 Promore Pharma Business Overview
  22. 8.4.3 Promore Pharma Venous Leg Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Promore Pharma Venous Leg Ulcers Treatment Product Portfolio
  24. 8.4.5 Promore Pharma Recent Developments
  25. 8.5 NovaLead Pharma Pvt Ltd
  26. 8.5.1 NovaLead Pharma Pvt Ltd Company Information
  27. 8.5.2 NovaLead Pharma Pvt Ltd Business Overview
  28. 8.5.3 NovaLead Pharma Pvt Ltd Venous Leg Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 NovaLead Pharma Pvt Ltd Venous Leg Ulcers Treatment Product Portfolio
  30. 8.5.5 NovaLead Pharma Pvt Ltd Recent Developments
  31. 8.6 MediWound Ltd
  32. 8.6.1 MediWound Ltd Company Information
  33. 8.6.2 MediWound Ltd Business Overview
  34. 8.6.3 MediWound Ltd Venous Leg Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MediWound Ltd Venous Leg Ulcers Treatment Product Portfolio
  36. 8.6.5 MediWound Ltd Recent Developments
  37. 8.7 Leap Therapeutics Inc
  38. 8.7.1 Leap Therapeutics Inc Company Information
  39. 8.7.2 Leap Therapeutics Inc Business Overview
  40. 8.7.3 Leap Therapeutics Inc Venous Leg Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Leap Therapeutics Inc Venous Leg Ulcers Treatment Product Portfolio
  42. 8.7.5 Leap Therapeutics Inc Recent Developments
  43. 8.8 Hypo-Stream Ltd
  44. 8.8.1 Hypo-Stream Ltd Company Information
  45. 8.8.2 Hypo-Stream Ltd Business Overview
  46. 8.8.3 Hypo-Stream Ltd Venous Leg Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hypo-Stream Ltd Venous Leg Ulcers Treatment Product Portfolio
  48. 8.8.5 Hypo-Stream Ltd Recent Developments
  49. 8.9 GangaGen Inc
  50. 8.9.1 GangaGen Inc Company Information
  51. 8.9.2 GangaGen Inc Business Overview
  52. 8.9.3 GangaGen Inc Venous Leg Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GangaGen Inc Venous Leg Ulcers Treatment Product Portfolio
  54. 8.9.5 GangaGen Inc Recent Developments
  55. 8.10 FirstString Research Inc
  56. 8.10.1 FirstString Research Inc Company Information
  57. 8.10.2 FirstString Research Inc Business Overview
  58. 8.10.3 FirstString Research Inc Venous Leg Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 FirstString Research Inc Venous Leg Ulcers Treatment Product Portfolio
  60. 8.10.5 FirstString Research Inc Recent Developments
  61. 8.11 Factor Therapeutics Ltd
  62. 8.11.1 Factor Therapeutics Ltd Company Information
  63. 8.11.2 Factor Therapeutics Ltd Business Overview
  64. 8.11.3 Factor Therapeutics Ltd Venous Leg Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Factor Therapeutics Ltd Venous Leg Ulcers Treatment Product Portfolio
  66. 8.11.5 Factor Therapeutics Ltd Recent Developments
  67. 8.12 Daval International Ltd
  68. 8.12.1 Daval International Ltd Company Information
  69. 8.12.2 Daval International Ltd Business Overview
  70. 8.12.3 Daval International Ltd Venous Leg Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Daval International Ltd Venous Leg Ulcers Treatment Product Portfolio
  72. 8.12.5 Daval International Ltd Recent Developments
  73. 8.13 CytoTools AG
  74. 8.13.1 CytoTools AG Company Information
  75. 8.13.2 CytoTools AG Business Overview
  76. 8.13.3 CytoTools AG Venous Leg Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CytoTools AG Venous Leg Ulcers Treatment Product Portfolio
  78. 8.13.5 CytoTools AG Recent Developments
  79. 8.14 CardioVascular BioTherapeutics Inc
  80. 8.14.1 CardioVascular BioTherapeutics Inc Company Information
  81. 8.14.2 CardioVascular BioTherapeutics Inc Business Overview
  82. 8.14.3 CardioVascular BioTherapeutics Inc Venous Leg Ulcers Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CardioVascular BioTherapeutics Inc Venous Leg Ulcers Treatment Product Portfolio
  84. 8.14.5 CardioVascular BioTherapeutics Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Venous Leg Ulcers Treatment Value Chain Analysis
  2. 9.1.1 Venous Leg Ulcers Treatment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Venous Leg Ulcers Treatment Production Mode & Process
  6. 9.2 Venous Leg Ulcers Treatment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Venous Leg Ulcers Treatment Distributors
  9. 9.2.3 Venous Leg Ulcers Treatment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst